Related Experiment Video
Updated: Jul 20, 2026
04:14
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
Published on: April 16, 2019
[Non-alcoholic liver disease (NASH)].
1Städtische Kliniken Esslingen, Leberzentrum, Esslingen. kp.maier@kliniken-es.de
Praxis
|September 8, 2006
Summary
Non-alcoholic steatohepatitis (NASH) is a growing liver disease similar to alcoholic liver disease but without alcohol abuse. Weight reduction may improve NASH, with liver transplantation as a last resort.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Non-alcoholic steatohepatitis (NASH) is a prevalent liver condition mirroring alcoholic liver disease in non-alcohol-abusing patients.
- Key factors in NASH development include obesity, insulin resistance, and oxidative stress.
- Distinguishing simple steatosis from NASH is crucial as simple steatosis often has a better prognosis.
Purpose of the Study:
- To review the pathogenesis, diagnosis, and treatment of Non-alcoholic steatohepatitis (NASH).
- To highlight the limitations of current diagnostic methods for NASH.
- To discuss potential therapeutic strategies for NASH.
Main Methods:
- Review of current literature on NASH.
- Analysis of diagnostic modalities, focusing on liver biopsy.
- Evaluation of existing and potential treatment options.
Main Results:
- Liver biopsy is the definitive method for differentiating steatosis from steatohepatitis.
- Liver enzymes are unreliable for NASH diagnosis and fibrosis staging.
- No consistently effective medical therapies are currently available for NASH.
Conclusions:
- Weight reduction is a recommended intervention for improving NASH.
- Liver transplantation is a viable option for end-stage liver disease caused by NASH.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:30Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...